What is he best known for?
The fields of study he is best known for:
Yuquan Wei mainly focuses on Cancer research, Apoptosis, In vivo, Cell biology and Ethylene glycol.
Yuquan Wei has researched Cancer research in several fields, including Cancer, Internal medicine, Metastasis and Immunology.
His Apoptosis research is multidisciplinary, incorporating perspectives in Cancer cell, Flow cytometry and Cell growth.
The In vivo study combines topics in areas such as In vitro, Biochemistry, Stereochemistry and Pharmacology.
In his work, Reactive oxygen species, Intracellular and Protein kinase B is strongly intertwined with Autophagy, which is a subfield of Cell biology.
The concepts of his Ethylene glycol study are interwoven with issues in Copolymer, Caprolactone, Drug delivery, Polymer chemistry and Biomedical engineering.
His most cited work include:
- Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. (516 citations)
- Correction: Corrigendum: MicroRNA-302b augments host defense to bacteria by regulating inflammatory responses via feedback to TLR/IRAK4 circuits (460 citations)
- A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. (260 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cancer research, Apoptosis, Cancer, Molecular biology and In vivo.
In his study, Pathology is inextricably linked to Metastasis, which falls within the broad field of Cancer research.
His study looks at the relationship between Apoptosis and topics such as Cell biology, which overlap with Autophagy.
His research in Cancer intersects with topics in Lung cancer and Oncology.
His Molecular biology research is multidisciplinary, incorporating elements of Cell culture, Cationic liposome, Transfection, Recombinant DNA and Western blot.
His In vivo research incorporates themes from In vitro, Genetic enhancement and Pharmacology.
He most often published in these fields:
- Cancer research (30.85%)
- Apoptosis (16.38%)
- Cancer (15.14%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (30.85%)
- Cancer (15.14%)
- Cell biology (10.40%)
In recent papers he was focusing on the following fields of study:
Cancer research, Cancer, Cell biology, Immune system and Apoptosis are his primary areas of study.
His Cancer research study combines topics in areas such as Cancer cell, Colorectal cancer, Lung cancer and Metastasis.
Lung cancer and T cell are commonly linked in his work.
His biological study spans a wide range of topics, including Blockade, Clinical trial and Oncology.
As part of his studies on Cell biology, Yuquan Wei often connects relevant areas like Receptor.
His Apoptosis study frequently draws connections to adjacent fields such as In vivo.
Between 2017 and 2021, his most popular works were:
- Targeting PI3K in cancer: mechanisms and advances in clinical trials (245 citations)
- A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. (159 citations)
- Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer. (81 citations)
In his most recent research, the most cited papers focused on:
Yuquan Wei mainly focuses on Cancer research, Cancer, Metastasis, Cell biology and Immunotherapy.
He combines subjects such as Apoptosis, Colorectal cancer, Ovarian cancer and DNA methylation with his study of Cancer research.
His Apoptosis research incorporates elements of Immunology and Sorafenib.
The study incorporates disciplines such as Clinical trial, Oncology and Function in addition to Cancer.
His research integrates issues of Cancer cell, Oncogene, Targeted therapy, Breast cancer and STAT3 in his study of Metastasis.
His work deals with themes such as Host–pathogen interaction, Innate immune system and Cell growth, which intersect with Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
